AgraFlora Organics International Inc. (OTCMKTS:AGFAF) has announced that it received a Standard Processing License on December 11, 2020, for Health Canada for its 51,000 sq. ft. fully-automated edibles manufacturing facility in Winnipeg, Manitoba.
AgraFlora Receives manufacturing license for Edibles facility
EIC co-Founder and Operations Manager James Fletcher stated that they are delighted to be awarded the Manufacturing License for the Edibles Facility within the speculated timeline. Fletcher added that the company’s string evidence package submission is proof of the hard-working team the company has assembled. He added that the company can commercialize its formulations and sell cannabis-activated gelatin and pectin gummies, sugar-free variants, and hard candy.
AgraFlora will continue focusing on completing long-term production relationships through the recently announced Research and Development trials. The company received a CRA tax license to create test cannabis edibles through its Health Canada Research and Development Lab License in the 51,000 sq. ft. Winnipeg manufacturing facility. AgraFlora has dialed in formulations for cannabis-activated gelatin and pectin gummies, sugar-free variants, and hard candy.
Fletcher said that as part of the R&D program, the company has commenced a testing project to enhance methods, standards and boost quality. He said that the company’s highly automated and efficient R&D production allows the company to offer a range of sample products for its potential clients to establish brands.
AgraFlora to launch cannabis edibles
Recently the company acquired High-Performance Liquid Chromatography equipment for the Winnipeg manufacturing facility. This will allow AgraFlora to develop and launch cannabis edibles that have been formulated quickly. The company is popular for growing, distributing, and marketing cannabis products and cannabis-infused products. AgraFlora’s strategy is divided into two, which involves serving the recreational market in Canada with high-quality cannabis flowers and edibles as well as serving the medical cannabis market in Europe.
The company indicated that it will roll out its first cannabis sales in the second quarter of 2021 from its cultivation operations at the British Columbia Delta facility. The facility will produce 10,000 plants that yield 50g per plant.